HK Stock MarketDetailed Quotes

00383 TIANAN MEDICARE

Watchlist

0.750
0.0000.00%

Market Closed Jul 11 16:09 CST

814.50MMarket Cap75.00P/E (TTM)

TIANAN MEDICARE Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

(FY)Dec 31, 2019

(Q6)Dec 31, 2018

Turnover

9.11%1.57B

3.39%760.95M

-1.75%1.44B

3.86%736.02M

22.56%1.46B

49.84%708.67M

-35.15%1.19B

--472.94M

--1.84B

--594.16M

Operating income

9.11%1.57B

3.39%760.95M

-1.75%1.44B

3.86%736.02M

22.56%1.46B

49.84%708.67M

-35.15%1.19B

472.94M

1.84B

594.16M

Cost of sales

-9.41%-1.28B

0.64%-614.58M

1.98%-1.17B

-8.12%-618.55M

-22.87%-1.2B

-48.35%-572.11M

34.21%-973.42M

---385.64M

---1.48B

---470.12M

Operating expenses

-9.41%-1.28B

0.64%-614.58M

1.98%-1.17B

-8.12%-618.55M

-22.87%-1.2B

-48.35%-572.11M

34.21%-973.42M

-385.64M

-1.48B

-470.12M

Gross profit

7.78%286.22M

24.61%146.38M

-0.71%265.56M

-13.98%117.47M

21.17%267.46M

56.43%136.56M

-38.98%220.73M

87.3M

361.73M

124.03M

Selling expenses

-42.49%-5.75M

-775.48%-2.71M

-51.33%-4.04M

82.05%-310K

20.44%-2.67M

-98.28%-1.73M

48.57%-3.35M

---871K

---6.52M

---2.71M

Administrative expenses

9.48%-231.01M

3.38%-118.42M

-14.57%-255.21M

-6.37%-122.56M

0.88%-222.76M

-8.92%-115.23M

37.10%-224.73M

---105.79M

---357.31M

---131.49M

Impairment and provision

----

---34.04M

----

-Goodwill impairment

----

---34.04M

----

Special items of operating profit

152.36%33.75M

297.53%4.08M

-7.07%-64.46M

95.82%-2.06M

-53.23%-60.2M

-90.01%-49.4M

-176.93%-39.29M

---26M

--51.07M

--5.64M

Operating profit

243.09%83.21M

492.69%29.32M

-11.36%-58.15M

74.94%-7.47M

-11.96%-52.22M

34.33%-29.79M

-195.23%-46.64M

-45.36M

48.98M

-4.53M

Financing cost

18.99%-47.81M

16.00%-26.52M

-1.32%-59.02M

-5.48%-31.57M

-16.68%-58.25M

-36.72%-29.93M

35.82%-49.92M

---21.89M

---77.79M

---25.72M

Earning before tax

130.22%35.4M

107.18%2.8M

-6.07%-117.17M

34.63%-39.04M

-14.40%-110.47M

11.20%-59.72M

-235.16%-96.56M

-67.25M

-28.81M

-30.25M

Tax

-654.66%-14.91M

-189.90%-2.24M

88.24%-1.98M

87.26%-772K

-95.90%-16.8M

-819.27%-6.06M

-122.21%-8.58M

---659K

--38.61M

--52.42M

After-tax profit from continuing operations

117.20%20.49M

101.42%564K

6.38%-119.15M

39.48%-39.81M

-21.05%-127.27M

3.14%-65.78M

-1,172.85%-105.14M

-67.91M

9.8M

22.17M

Earning after tax

117.20%20.49M

101.42%564K

6.38%-119.15M

39.48%-39.81M

-21.05%-127.27M

3.14%-65.78M

-1,172.85%-105.14M

-67.91M

9.8M

22.17M

Minority profit

107.65%9.2M

-43.33%2.32M

-55.82%4.43M

-49.61%4.09M

47.68%10.03M

286.12%8.12M

-10.95%6.79M

--2.1M

--7.62M

---559K

Profit attributable to shareholders

109.14%11.3M

96.00%-1.76M

9.99%-123.57M

40.59%-43.9M

-22.66%-137.3M

-5.55%-73.9M

-5,243.75%-111.93M

-70.02M

2.18M

22.73M

Basic earnings per share

107.20%0.0122

96.18%-0.0023

10.65%-0.1694

-1,080.39%-0.0602

-2,362.34%-0.1896

-6.25%-0.0051

-3,950.00%-0.0077

-0.0048

0.0002

0.0016

Diluted earnings per share

0.0002

0.0016

Currency Unit

HKD

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Hong Kong Lixin Dehao Certified Public Accountants Limited

Luo Shenmei Certified Public Accountants

Deloitte & Touche Tohmatsu Certified Public Accountants

	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020	(FY)Dec 31, 2019	(Q6)Dec 31, 2018
Turnover	9.11%1.57B	3.39%760.95M	-1.75%1.44B	3.86%736.02M	22.56%1.46B	49.84%708.67M	-35.15%1.19B	--472.94M	--1.84B	--594.16M
Operating income	9.11%1.57B	3.39%760.95M	-1.75%1.44B	3.86%736.02M	22.56%1.46B	49.84%708.67M	-35.15%1.19B	472.94M	1.84B	594.16M
Cost of sales	-9.41%-1.28B	0.64%-614.58M	1.98%-1.17B	-8.12%-618.55M	-22.87%-1.2B	-48.35%-572.11M	34.21%-973.42M	---385.64M	---1.48B	---470.12M
Operating expenses	-9.41%-1.28B	0.64%-614.58M	1.98%-1.17B	-8.12%-618.55M	-22.87%-1.2B	-48.35%-572.11M	34.21%-973.42M	-385.64M	-1.48B	-470.12M
Gross profit	7.78%286.22M	24.61%146.38M	-0.71%265.56M	-13.98%117.47M	21.17%267.46M	56.43%136.56M	-38.98%220.73M	87.3M	361.73M	124.03M
Selling expenses	-42.49%-5.75M	-775.48%-2.71M	-51.33%-4.04M	82.05%-310K	20.44%-2.67M	-98.28%-1.73M	48.57%-3.35M	---871K	---6.52M	---2.71M
Administrative expenses	9.48%-231.01M	3.38%-118.42M	-14.57%-255.21M	-6.37%-122.56M	0.88%-222.76M	-8.92%-115.23M	37.10%-224.73M	---105.79M	---357.31M	---131.49M
Impairment and provision	----	----	----	----	---34.04M	----	----	----	----	----
-Goodwill impairment	----	----	----	----	---34.04M	----	----	----	----	----
Special items of operating profit	152.36%33.75M	297.53%4.08M	-7.07%-64.46M	95.82%-2.06M	-53.23%-60.2M	-90.01%-49.4M	-176.93%-39.29M	---26M	--51.07M	--5.64M
Operating profit	243.09%83.21M	492.69%29.32M	-11.36%-58.15M	74.94%-7.47M	-11.96%-52.22M	34.33%-29.79M	-195.23%-46.64M	-45.36M	48.98M	-4.53M
Financing cost	18.99%-47.81M	16.00%-26.52M	-1.32%-59.02M	-5.48%-31.57M	-16.68%-58.25M	-36.72%-29.93M	35.82%-49.92M	---21.89M	---77.79M	---25.72M
Earning before tax	130.22%35.4M	107.18%2.8M	-6.07%-117.17M	34.63%-39.04M	-14.40%-110.47M	11.20%-59.72M	-235.16%-96.56M	-67.25M	-28.81M	-30.25M
Tax	-654.66%-14.91M	-189.90%-2.24M	88.24%-1.98M	87.26%-772K	-95.90%-16.8M	-819.27%-6.06M	-122.21%-8.58M	---659K	--38.61M	--52.42M
After-tax profit from continuing operations	117.20%20.49M	101.42%564K	6.38%-119.15M	39.48%-39.81M	-21.05%-127.27M	3.14%-65.78M	-1,172.85%-105.14M	-67.91M	9.8M	22.17M
Earning after tax	117.20%20.49M	101.42%564K	6.38%-119.15M	39.48%-39.81M	-21.05%-127.27M	3.14%-65.78M	-1,172.85%-105.14M	-67.91M	9.8M	22.17M
Minority profit	107.65%9.2M	-43.33%2.32M	-55.82%4.43M	-49.61%4.09M	47.68%10.03M	286.12%8.12M	-10.95%6.79M	--2.1M	--7.62M	---559K
Profit attributable to shareholders	109.14%11.3M	96.00%-1.76M	9.99%-123.57M	40.59%-43.9M	-22.66%-137.3M	-5.55%-73.9M	-5,243.75%-111.93M	-70.02M	2.18M	22.73M
Basic earnings per share	107.20%0.0122	96.18%-0.0023	10.65%-0.1694	-1,080.39%-0.0602	-2,362.34%-0.1896	-6.25%-0.0051	-3,950.00%-0.0077	-0.0048	0.0002	0.0016
Diluted earnings per share									0.0002	0.0016
Currency Unit	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--
Auditor	Hong Kong Lixin Dehao Certified Public Accountants Limited	--	Luo Shenmei Certified Public Accountants	--	Luo Shenmei Certified Public Accountants	--	Deloitte & Touche Tohmatsu Certified Public Accountants	--	Deloitte & Touche Tohmatsu Certified Public Accountants	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

00383 TIANAN MEDICARE

TIANAN MEDICARE Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target